# CVE-2023-30584: Node.js 20: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

CVE-2023-30584 is fixed in Node.js 20 on 1 platform by Node.js 20 20.3.1 (version 20.3.1), released June 20, 2023. It is not reported as exploited. Patch Radar priority: High.

- Web page: https://patchblox.com/security/cve/CVE-2023-30584
- Priority: High
- CVSS: 7.7
- EPSS: 0.0034
- CISA KEV: not listed
- Exploited (vendor report): no
- Publicly disclosed: no
- Published: Sep 7, 2024
- Weakness: CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
- Vendor advisory: https://nvd.nist.gov/vuln/detail/CVE-2023-30584

## Description

A vulnerability has been discovered in Node.js version 20, specifically within the experimental permission model. This flaw relates to improper handling of path traversal bypass when verifying file permissions.  Please note that at the time this CVE was issued, the permission model is an experimental feature of Node.js.

## Where it's fixed

| Platform | Product | Fixed in | Fix | Released |
|---|---|---|---|---|
| Windows apps | Node.js 20 | 20.3.1 | [Node.js 20 20.3.1](https://patchblox.com/security/data/fix/windows-app/openjs.nodejs.20-20.3.1.md) | Jun 20, 2023 |

---

Data as of 2026-11-09T07:25:28Z UTC. Source: Patchblox Patch Radar (https://patchblox.com/security/patch-radar). Patchblox finds out-of-date software on Windows, macOS and Linux and updates it through release rings: https://patchblox.com/demo

Free to use with attribution: show "Data: Patchblox Patch Radar" with a link to https://patchblox.com/security/patch-radar. Terms, including what needs a written agreement: https://patchblox.com/security/patch-radar/use-the-data

Product names, logos and trademarks shown on Patch Radar belong to their respective owners. They are used only to identify the software each security fix applies to and to help readers find their platform. Their use does not imply any affiliation with, or endorsement by, those owners, and Patchblox is not affiliated with any of them.